BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2663614)

  • 21. Resection of gastrinoma in the Zollinger-Ellison syndrome.
    Barreras RF; Mack E; Goodfriend T; Damm M
    Gastroenterology; 1982 May; 82(5 Pt 1):953-6. PubMed ID: 7060915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome.
    Thompson JC; Reeder DD; Villar HV; Fender HR
    Surg Gynecol Obstet; 1975 May; 140(5):721-39. PubMed ID: 1145407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome.
    Mignon M; Rigaud D; Cambray S; Chayvialle JA; Accary JP; René E; Vatier J; Bonfils S
    Scand J Gastroenterol; 1985 Sep; 20(7):791-7. PubMed ID: 4048832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of parathyroidectomy or calcium channel blockade on serum gastrin concentration and gastric acid secretion in a patient with hyperparathyroidism and Zollinger-Ellison syndrome.
    Stevens MH; Thirlby RC; Richardson CT
    Surgery; 1987 Jan; 101(1):108-13. PubMed ID: 3798319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Zollinger-Ellison syndrome of ovarian origin. Apropos of a case with a review of the literature].
    de Broucker F; Caudron C; Sournia V; Adamsbaum C; Levesque M
    J Radiol; 1989 Feb; 70(2):111-4. PubMed ID: 2654382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of the Zollinger-Ellison syndrome in pregnancy.
    Stewart CA; Termanini B; Sutliff VE; Corleto VD; Weber HC; Gibril F; Jensen RT
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):224-33. PubMed ID: 9024119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
    Lamers CG; Van Tongeren JH
    Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudo-Zollinger--Ellison syndrome in a child presenting with anemia.
    Zaatar R; Younoszai MK; Mitros F
    Gastroenterology; 1987 Feb; 92(2):508-12. PubMed ID: 3792786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zollinger-Ellison syndrome. Current concepts in diagnosis and management.
    Wolfe MM; Jensen RT
    N Engl J Med; 1987 Nov; 317(19):1200-9. PubMed ID: 3309661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zollinger-Ellison syndrome associated with persistently normal fasting serum gastrin concentrations.
    Wolfe MM; Jain DK; Edgerton JR
    Ann Intern Med; 1985 Aug; 103(2):215-7. PubMed ID: 4014903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new cause of Zollinger-Ellison syndrome: non-small cell lung cancer.
    Abou-Saif A; Lei J; McDonald TJ; Chakrabarti S; Waxman IF; Shojamanesh H; Schrump DS; Kleiner DE; Gibril F; Jensen RT
    Gastroenterology; 2001 Apr; 120(5):1271-8. PubMed ID: 11266390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting somatostatin analog controls acid and gastrin secretion in benign, not in malignant, Zollinger-Ellison syndrome.
    Bauer FE; Hummel M; Merki HS; Schulz E; Oeder R; Marbach P
    J Clin Gastroenterol; 1989 Jun; 11(3):282-6. PubMed ID: 2754214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.
    Hirschowitz BI
    Yale J Biol Med; 1992; 65(6):659-76; discussion 689-92. PubMed ID: 1341070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet cell tumors and the ulcerogenic syndrome.
    McGuigan JE
    Monogr Pathol; 1980; 21():177-84. PubMed ID: 6261121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor.
    Friesen SR; Tomita T
    Ann Surg; 1981 Oct; 194(4):481-93. PubMed ID: 7283508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection.
    Fraker DL; Norton JA; Saeed ZA; Maton PN; Gardner JD; Jensen RT
    Surgery; 1988 Dec; 104(6):1054-63. PubMed ID: 2904182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a gastrin-receptor antagonist on gastric acid secretion and serum gastrin in the Zollinger-Ellison syndrome.
    Lamers CB; Jansen JB
    J Clin Gastroenterol; 1983 Feb; 5(1):21-4. PubMed ID: 6841943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.